Effect of PPAR gamma ligand on endothelial dysfunction induced by ischemia-reperfusion injury

Effect of PPAR gamma ligand on endothelial dysfunction induced by ischemia-reperfusion injury - Effect of PPAR gamma ligand on endothelial dysfunction induced by ischemia-reperfusion injury

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012583

Enrollment

Registered

2013-12-16

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healty individuals

Interventions

pioglitazone No treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.From age 25 years old to 85 years old 2.Sex is not asked 3.Healthy volunteer 4.Subjects who received written informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects receiving hypoglycemic agents and lipid lowering agents 2. Subjects who is allergic to omega-3 fatty acid 3.Patients who are determined by the investigators to be unsuitable

Design outcomes

Primary

Measure	Time frame
Change in endothelial dysfunction induced by ischemia-reperfusion injury after treatment of PPAR gamma ligand	—

Countries

Japan

Contacts

Public ContactToru Miyoshi

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Department of Cardiovascular Medicine

miyoshit@cc.okayama-u.ac.jp086-235-7351

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026